Publisher
Springer Science and Business Media LLC
Reference81 articles.
1. Compston, A. & Coles, A. Multiple sclerosis. The Lancet 372, 1502–1517 (2008).
2. Wingerchuk, D. M. & Weinshenker, B. G. Disease modifying therapies for relapsing multiple sclerosis. BMJ 354 (2016).
3. Ontaneda, D., Fox, R. J. & Chataway, J. Clinical trials in progressive multiple sclerosis: lessons learned and future perspectives. Lancet Neurology 14, 208–223 (2015).
4. Torkildsen, Ø., Myhr, K. & Bø, L. Disease modifying treatments for multiple sclerosis – a review of approved medications. European Journal of Neurology 23, 18–27 (2016).
5. Shirani, A. et al. Association Between Use of Interferon Beta and Progression of Disability in Patients With Relapsing- Remitting Multiple Sclerosis. JAMA 308, 247–256 (2012).
Cited by
11 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献